Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Granger

Showing results (411-420 of 910) with videos related to

Pageof 91
Sort By:
Diabetes, Obesity & Metabolism|February 6, 2024
Effect of albiglutide on cardiovascular outcomes in older adults: A post hoc analysis of a randomized controlled trialMatthew P Gilbert, Joan Skelly, Adrian F Hernandez, et al.
American Heart Journal|March 20, 2019
Peripheral blood metabolite profiles associated with new onset atrial fibrillationRalf E Harskamp, Thomas M Granger, Robert M Clare, et al.
Journal of Interventional Cardiology|September 21, 2007
Timing of death and myocardial infarction in patients with non-ST elevation acute coronary syndromes: insights from randomized clinical trialsRajendra H Mehta, Adam B Greenbaum, Yuliya Lokhnygina, et al.
Journal of the American College of Cardiology|February 4, 2022
Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous InterventionRalf E Harskamp, Alexander C Fanaroff, Renato D Lopes, et al.
Lancet (London, England)|August 18, 2009
Albuminuria in chronic heart failure: prevalence and prognostic importanceColette E Jackson, Scott D Solomon, Hertzel C Gerstein, et al.
Journal of the American Heart Association|May 8, 2020
Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical TherapyMika Hilvo, Lars Wallentin, Tatevik Ghukasyan Lakic, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 24, 2014
Use of antiarrhythmic drug therapy and clinical outcomes in older patients with concomitant atrial fibrillation and coronary artery diseaseBenjamin A Steinberg, Samuel H Broderick, Renato D Lopes, et al.
Circulation|October 7, 2004
Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) programScott D Solomon, Duolao Wang, Peter Finn, et al.
American Heart Journal|October 8, 2005
Electrocardiographic infarct size assessment after thrombolysis: insights from the Acute Myocardial Infarction STudy ADenosine (AMISTAD) trialAlejandro Barbagelata, Marcelo F Di Carli, Robert M Califf, et al.
JAMA Cardiology|December 16, 2020
Assessing the Role of Rare Genetic Variation in Patients With Heart FailureGundula Povysil, Olympe Chazara, Keren J Carss, et al.
Pageof 91

Showing results (411-420 of 910) with videos related to

Sort By:
Pageof 91
Diabetes, Obesity & Metabolism|February 6, 2024
Effect of albiglutide on cardiovascular outcomes in older adults: A post hoc analysis of a randomized controlled trialMatthew P Gilbert, Joan Skelly, Adrian F Hernandez, et al.
American Heart Journal|March 20, 2019
Peripheral blood metabolite profiles associated with new onset atrial fibrillationRalf E Harskamp, Thomas M Granger, Robert M Clare, et al.
Journal of Interventional Cardiology|September 21, 2007
Timing of death and myocardial infarction in patients with non-ST elevation acute coronary syndromes: insights from randomized clinical trialsRajendra H Mehta, Adam B Greenbaum, Yuliya Lokhnygina, et al.
Journal of the American College of Cardiology|February 4, 2022
Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous InterventionRalf E Harskamp, Alexander C Fanaroff, Renato D Lopes, et al.
Lancet (London, England)|August 18, 2009
Albuminuria in chronic heart failure: prevalence and prognostic importanceColette E Jackson, Scott D Solomon, Hertzel C Gerstein, et al.
Journal of the American Heart Association|May 8, 2020
Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical TherapyMika Hilvo, Lars Wallentin, Tatevik Ghukasyan Lakic, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 24, 2014
Use of antiarrhythmic drug therapy and clinical outcomes in older patients with concomitant atrial fibrillation and coronary artery diseaseBenjamin A Steinberg, Samuel H Broderick, Renato D Lopes, et al.
Circulation|October 7, 2004
Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) programScott D Solomon, Duolao Wang, Peter Finn, et al.
American Heart Journal|October 8, 2005
Electrocardiographic infarct size assessment after thrombolysis: insights from the Acute Myocardial Infarction STudy ADenosine (AMISTAD) trialAlejandro Barbagelata, Marcelo F Di Carli, Robert M Califf, et al.
JAMA Cardiology|December 16, 2020
Assessing the Role of Rare Genetic Variation in Patients With Heart FailureGundula Povysil, Olympe Chazara, Keren J Carss, et al.
Pageof 91